Unihealth Hospitals completes first IVUS-guided coronary intervention
Unihealth Hospitals Limited successfully conducted its first IVUS-guided coronary intervention at UMC Hospitals, Navi Mumbai, enhancing cardiac care precision. The procedure, performed by Dr. Shrikant Naigude, improves stent placement accuracy and patient safety. For FY26, the company reported a Total Income of ₹137.01 Cr, EBITDA of ₹58.82 Cr, and Net Profit of ₹25.83 Cr.

*this image is generated using AI for illustrative purposes only.
unihealth hospitals announced the successful completion of its first Intravascular Ultrasound (IVUS)-guided coronary intervention at UMC Hospitals in Navi Mumbai on June 17, 2026. This milestone marks a significant advancement in the hospital's cardiac care capabilities, enhancing the precision of treatments for coronary artery disease. The procedure was performed by Dr. Shrikant Naigude, utilizing advanced imaging technology to visualize artery walls and optimize stent deployment.
The adoption of IVUS technology offers several clinical advantages, including enhanced procedural accuracy and improved long-term outcomes. By providing detailed cross-sectional images of the vessel wall, the technology allows cardiologists to accurately assess blockages and ensure precise stent expansion. This reduces the risk of complications such as stent thrombosis and lowers the likelihood of restenosis, or the re-narrowing of arteries.
Financial Performance for FY26
Unihealth Hospitals Limited reported strong financial results for the fiscal year ended March 31, 2026. The company achieved growth across key operational metrics, reflecting its focus on expanding healthcare infrastructure and services.
| Metric | Amount (₹) |
|---|---|
| Total Income | 137.01 Cr |
| EBITDA | 58.82 Cr |
| Net Profit | 25.83 Cr |
Strategic Expansion and Clinical Excellence
The successful execution of the IVUS-guided procedure aligns with the company's strategy to invest in advanced medical technologies and evidence-based treatment protocols. Dr. Akshay Parmar, Founder and Managing Director of Unihealth Hospitals Limited, stated that the introduction of this technology reflects the company's commitment to bringing globally accepted healthcare solutions to the communities it serves.
UMC Hospitals offers a broad spectrum of medical and surgical specialties, including cardiology, critical care, and orthopaedics. The facility is supported by modern catheterization laboratory infrastructure and multidisciplinary teams dedicated to comprehensive cardiovascular care. This initiative is part of a broader effort to strengthen the company's position as a centre for quality healthcare delivery in the Mumbai Metropolitan Region.
Historical Stock Returns for Unihealth Hospitals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.78% | +23.03% | +24.09% | +75.91% | +228.00% | +331.58% |
How will the adoption of IVUS technology impact UMC Hospitals' patient volume and market share in the competitive Mumbai Metropolitan Region?
What are the projected capital expenditure requirements for scaling IVUS capabilities to other Unihealth facilities?
Will the introduction of premium IVUS procedures lead to an increase in average revenue per inpatient for FY27?






























